Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing TherapeuticsBusiness Wire • 11/02/21
FDA Delays Approval For Moderna's COVID-19 Shot In Teenagers: What You Need To KnowBenzinga • 11/01/21
Moderna Announces Pledge to Achieve Net-Zero Carbon Emissions Globally by 2030Business Wire • 11/01/21
Moderna says FDA needs more time to review COVID vaccine in 12-to-17-year oldsMarket Watch • 11/01/21
Moderna Provides Update on Timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for AdolescentsBusiness Wire • 10/31/21
Moderna Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income CountriesBusiness Wire • 10/29/21
Moderna (MRNA) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/28/21
Moderna (MRNA) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 10/27/21